Got 90 seconds? Then listen to Uscom Limited Executive Chairman, CEO & Chief Scientist Rob Phillips tell us more about the company, its recent placement and near-term outlook

Uscom Limited (ASX: UCM) is an Australian medical device company specialising in the development and marketing of premium non-invasive cardiovascular and pulmonary medical devices.

Uscom recently announced a private placement to management and major shareholders.  The capital will be used to  finalise the costs of China and US regulatory approvals, build new USCOM 1A, BP+ and SpiroSonic devices following record manufacturing in June, and to support new marketing initiatives in China, Europe and the US.

We gave Uscom Executive Chairman, CEO and Chief Scientist, Rob Phillips 90 Seconds to tell us about the company, its recent placement and the outlook for Uscom in the near term.

Have a good idea for our next 90 Seconds With segment? Email us at tv@stockhead.com.au.